Dr. Mayra Cristina Beauchamp Bruno, MD

Dr. Beauchamp Bruno practices at Novant Health Winston Salem Cardiology in Winston Salem, North Carolina.

Dr. Beauchamp Bruno's NPI, 1003015173, was assigned on July 17, 2007. Dr. Beauchamp Bruno graduated from University of Puerto Rico School of Medicine in 2005. Dr. Beauchamp Bruno holds New Hampshire license 16259.

Dr. Beauchamp Bruno's primary practice is Novant Health Winston Salem Cardiology, at 250 Charlois Blvd, Winston Salem, NC 27103 in Forsyth County. The practice phone is (336) 277-2000.

Dr. Beauchamp Bruno's primary practice is Novant Health Winston Salem Cardiology in Winston Salem, North Carolina. Dr. Beauchamp Bruno is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Beauchamp Bruno to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beauchamp Bruno practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Beauchamp Bruno's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Beauchamp Bruno is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Beauchamp Bruno's licenses on file in 2 states: New Hampshire and Puerto Rico.

CMS data shows 4,446 Medicare services from Dr. Beauchamp Bruno across 22 procedure codes in 2024, for 1,011 Medicare patients. Medicare paid $120,866 for them. Every service was in an office.

CMS counts 1,011 Medicare patients who saw Dr. Beauchamp Bruno in 2024. The largest group is 65 to 74, with 481 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Beauchamp Bruno's median patient age at 70, with 57% women.

In 2024, Dr. Beauchamp Bruno wrote 1,770 Medicare Part D claims for 554 patients. 87% of them were for generic drugs. CMS names the drug for 1,560 of them, across 40 drugs with 11 or more claims each, at $1,453,315 in total drug cost. In 2023, CMS named 1,109 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Beauchamp Bruno for performance year 2024, reported through an alternative payment model (APM). Dr. Beauchamp Bruno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,189 procedures of removal of skin lesions by Dr. Beauchamp Bruno, more than 95% of the clinicians it reports for that procedure.

Dmand AI links Dr. Beauchamp Bruno to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 88 general payments to Dr. Beauchamp Bruno from 11 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $251.

Dr. Beauchamp Bruno graduated from University of Puerto Rico School of Medicine in 2005.